Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03077516 · ClinicalTrials.gov registry record

Post-Market, Long-Term Follow Up of Mobi-C® Cervical Disc for One and Two Level Treatment of Cervical Disc Disease

A clinical trial of Cervical Disc Disease and Cervical Disc Degeneration, sponsored by LDR Spine U.

Completed
Registry status
216
Enrollment target
8
Study locations

NCT03077516 is a study of Cervical Disc Disease and Cervical Disc Degeneration that has completed, run by LDR Spine U. The registered enrollment target is 216 participants, above the 150-participant average among 3 other Cervical Disc Disease trials with a reported enrollment target (44% higher). The trial reports 8 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03077516, a study of Cervical Disc Disease and Cervical Disc Degeneration, has completed, sponsored by LDR Spine U.

COMPLETED
Registry status
216 participants
Enrollment target
8
Study locations

Study Summary

The purpose of this study is to evaluate clinical and patient-reported outcomes at 10 years following surgery for a cohort of Mobi-C subjects treated on the IDE/Post Approval studies

Interventions

  • DEVICE Mobi-C

Study Locations (8)

California

  • Orange County Neurosurgical Associates - Laguna Hills
  • Desert Orthopedic Center - Rancho Mirage
  • UC Davis Spine Center - Sacramento
  • The Spine Institute - Santa Monica

Texas

  • Texas Back Institute - Plano
  • Texas Spine and Joint Hospital - Tyler

Indiana

  • Orthopedics Northeast - Fort Wayne

Louisiana

  • Spine Institute of Louisiana - Shreveport

Trial Details

FieldValue
Enrollment Target 216 participants
Start Date 2016-11
Est. Completion 2019-10-31

Sponsor

LDR Spine U

1 total trials

What the Registry Record Tells You About NCT03077516

The ClinicalTrials.gov registry entry for NCT03077516 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 216 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 150-participant average among 3 other Cervical Disc Disease trials with a reported enrollment target (44% higher). The listed sponsor is LDR Spine U, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Cervical Disc Disease appearing as the primary indexed condition, and to 1 intervention - of which Mobi-C is the first listed.

NCT03077516 reports 8 study locations spanning 4 distinct geographic areas - top geographies include California, Texas, Indiana.

Frequently Asked Questions

What is clinical trial NCT03077516 about?

NCT03077516 is a clinical study titled "Post-Market, Long-Term Follow Up of Mobi-C® Cervical Disc for One and Two Level Treatment of Cervical Disc Disease". The purpose of this study is to evaluate clinical and patient-reported outcomes at 10 years following surgery for a cohort of Mobi-C subjects treated on the IDE/Post Approval studies

What is the current status of trial NCT03077516?

This trial is currently completed. The enrollment target is 216 participants. The study started on 2016-11. Estimated completion is 2019-10-31.

What conditions does trial NCT03077516 study?

This clinical trial studies the following conditions: Cervical Disc Disease, Cervical Disc Degeneration.

What interventions are being tested in trial NCT03077516?

The interventions under investigation include: Mobi-C (DEVICE).

Who is sponsoring clinical trial NCT03077516?

This trial is sponsored by LDR Spine U, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03077516 being conducted?

This trial has 8 study locations across California, Indiana, Louisiana, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cervical Disc Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.